Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study

OBJECTIVE: To evaluate whether liraglutide or roflumilast significantly affects body weight when compared to metformin in obese women with PCOS. DESIGN/MAIN OUTCOME MEASURE: A 12-week prospective randomized open-label study was conducted with 45 obese women with PCOS diagnosed by the ASRM-ESHRE Rott...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensterle, Mojca, Salamun, Vesna, Kocjan, Tomaz, Vrtacnik Bokal, Eda, Janez, Andrej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506413/
https://www.ncbi.nlm.nih.gov/pubmed/26032655
http://dx.doi.org/10.1186/s13048-015-0161-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506413/
https://www.ncbi.nlm.nih.gov/pubmed/26032655
http://dx.doi.org/10.1186/s13048-015-0161-3

Ejemplares similares